Young Kim, M.D., Ph.D., Associate Professor of Otolaryngology and
co-leader of the Translational Research and Interventional Oncology Research Program, is a clinician - scientist focused on the development of immunotherapeutic modalities for solid tumors.
She has also obtained a Breast Cancer
Research Foundation American Association for Cancer Research (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Di
Research Foundation American Association for Cancer
Research (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Di
Research (BCRF - AACR) Grant for
Translational Breast Cancer
Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Di
Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also
co-Leader in three
of the four
research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Di
research projects
of the NCI - funded Vanderbilt Breast Cancer Specialized Program
of Research Excellence (SPORE; Carlos Arteaga, Di
Research Excellence (SPORE; Carlos Arteaga, Director).
Co-Leader,
Translational Research and Interventional Oncology
Research Program Professor
of Medicine (Hematology / Oncology) Director, Outpatient Transplant Program Section Chief, Hematology and Stem Cell Transplant